1Fidler U- The pathogenesis of cancer metastasis : the 'seed and soil' hypothesis revisited [ J ] . Nat Rev Cancer, 2003, 3 ( 6 ) : 453-458.
2Pedersen LM, Milman N. Diagnostic significance of platelet count and other blood analyses in patients with lung cancer [ J ] . Oncol Rep, 2003, 10 ( 1 ) : 213-216.
3Borsig L. The role of p|atelet activation in tumor metastasis [ J ] . Expert Rev Anticancer Ther, 2008, 8 ( 8 ) : 1247-1255.
4Tesselaar ME, Osanto S. Risk of venous thromboembolism in lung cancer [ J ] . Curr Opin Pulm Med, 2007, 13 ( 5 ) : 362-367.
7Zhang Y, Duan LC, Xiang XD, et al .The relationship between the level of activation markers of platelets in peripheral blood around operation and lung cancer [ J ] . Chinese-German Journal of Clinical Oncology, 2008, 7 ( 2 ) : 84-86.
8T 0sada J, Rusak M, Kamocki Z, et al. Platelet activation in patients with advanced gastric cancer [ J ]. Neoplasma, 2010, 57 ( 2 ) : 145-150.
4Felding-Habermann B, Fransvea E, O'Toole TE, et al. Involvement of tumor cell integrin α V β3 in hematogenous metastasis of human melanoma cells. Clinical & Experimental Metastasis, 2002, 19(4) : 427-436
5Pilch J, Habermann R, Felding-Habermann B. Unique Ability of Integrln a V β3 to Support Tumor Cell Arrest under Dynamic Flow Conditions. J Biol Chem, 2002, 277 (24) : 21930-21938
6Lawler K, meade G, O'sullivan G. Shear stress modulates the interaction of platelet-secreted matrix proteins with tumor cells through the integrin α V βs. Am J Physiol Cell Physiol, 2004, 287(4) : C1320-C1327
7Gong W, Liu Y, Huang B, et al. Recombinant CBD-Hep Ⅱ polypeptide of fibronectin inhibits alpha V beta3 signaling and hematogenous metastasis of tumor. Biochem Biophys Res Commun, 2008,29,367( 1 ) :144-149
8Nash GF, Turner LF, Scully MF, et al. Platelet and cancer. The Lancet Oncology, 2002,3(10) :425-430
9Borsig L. The role of platclet activation in tumor metastasis. Expert Rev Anticancer Ther, 2008,8 ( 8 ) : 1247-1255
10Honn KV, Tang DG, Chen YQ. Platelets and cancer metastasis: more than an epiphenomenon. Semin Thromb Hemost, 1992,18 (4) :392-415